Clinical Trial Comparing Heparin and Protamine Fixed and Titrated Doses in Cardiac Surgery With Cardiopulmonary Bypass

Clinical Trial ID NCT01267487

PubWeight™ 0.00^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT01267487

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline.	Ann Thorac Surg	2007	5.32
2	Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage.	J Thorac Cardiovasc Surg	1975	2.44
3	The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.	J Thorac Cardiovasc Surg	1995	1.80
4	Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.	Can J Anaesth	1998	1.52
5	Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations.	J Thorac Cardiovasc Surg	1995	0.99
6	Anticoagulation management during cardiopulmonary bypass: a survey of 54 North American institutions.	J Thorac Cardiovasc Surg	2010	0.86
7	Can extra protamine eliminate heparin rebound following cardiopulmonary bypass surgery?	J Thorac Cardiovasc Surg	2004	0.83
8	The effects of heparin, protamine, and heparin/protamine reversal on platelet function under conditions of arterial shear stress.	Anesth Analg	2001	0.78
9	Anticoagulation management in patients undergoing open heart surgery by activated clotting time and whole blood heparin concentration.	Perfusion	2006	0.75
10	Anticoagulation and reversal paradigms: is too much of a good thing bad?	Anesth Analg	2009	0.75